In COVID-19, SARS-CoV-2 also activates both toll-like receptors (TLRs) and the NOD−, LRR−, and pyrin domain-containing protein 3 (NLRP3) inflammasome [4–12]. The gene discussed is NLRP3; the disease is COVID-19.